MMJ BioScience’s intellectual property portfolio includes multiple patent families with issued and/or pending claims directed to plants, plant extracts, patient monitoring technology, pharmaceutical formulations, drug delivery methods and the therapeutic uses of cannabinoids , as well as plant variety rights … Read More
The post MMJ International Holdings Announces US Patent Filing for Multiple Sclerosis Cannabinoid … appeared first on Dagga Magazine.